Alex Karp

Merck, the German multinational chemical and pharmaceutical company, is teaming up with Silicon Valley’s highest-profile data and analysis software company, Palantir, to more quickly develop new drugs and, hopefully, improve patient outcomes.
The idea at the start is for the companies to partner on three of Merck’s business sectors: healthcare, life sciences, and performance… Read More

Earlier this week, BuzzFeed got its hands on a stock purchase offer arranged by Palantir for its employees, one that asked current and former employees to agree to a host of stipulations. Among them, the 12-year-old, data analytics outfit asked former employees to renew their non-disclosure agreements, agree not to solicit Palantir employees for 12 months, and promise not to sue the company or… Read More

When Alex Karp needed funding for a young start up named Palantir in 2005, dozens of investors said “No.”
He was trying to sell them on the idea of a high-powered analysis platform that could scan multiple databases simultaneously— a tool that government officials and corporations could use to tackle complex problems.
“Enterprise is a dirty word and that’s the… Read More